MedPath

VALEANT PHARMACEUTICALS

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:1

Trial Phases

3 Phases

Phase 2:2
Phase 3:2
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (40.0%)
Phase 3
2 (40.0%)
Not Applicable
1 (20.0%)

A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris

Phase 2
Conditions
Acne Vulgaris
Interventions
Drug: IDP-120 Gel
Drug: IDP-120 Component A
Drug: IDP-120 Component B
Drug: IDP-120 Vehicle Gel
First Posted Date
2015-09-01
Last Posted Date
2015-09-14
Lead Sponsor
Valeant Pharmaceuticals
Target Recruit Count
350
Registration Number
NCT02537483

A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Phase 3
Conditions
Acne Vulgaris
Interventions
Drug: IDP-121 Vehicle Lotion
First Posted Date
2015-08-31
Last Posted Date
2015-09-14
Lead Sponsor
Valeant Pharmaceuticals
Target Recruit Count
800
Registration Number
NCT02535871

Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris

Phase 2
Conditions
Acne Vulgaris
Interventions
Drug: Vehicle Cream
Drug: Vehicle Lotion
First Posted Date
2015-08-17
Last Posted Date
2015-09-14
Lead Sponsor
Valeant Pharmaceuticals
Target Recruit Count
210
Registration Number
NCT02525822

A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Phase 3
Conditions
Acne Vulgaris
Interventions
Drug: IDP-121 Vehicle Lotion
First Posted Date
2015-07-07
Last Posted Date
2015-09-14
Lead Sponsor
Valeant Pharmaceuticals
Target Recruit Count
800
Registration Number
NCT02491060

Thermage CPT for Treatment of Facial and Neck Laxity

Not Applicable
Completed
Conditions
Skin Aging
First Posted Date
2013-02-05
Last Posted Date
2017-06-09
Lead Sponsor
Valeant Pharmaceuticals
Target Recruit Count
50
Registration Number
NCT01783496
Locations
🇺🇸

Solta Medical Aesthetic Center, Hayward, California, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.